Cronos Group

In race to win Europe, Aurora Cannabis and other Canadian companies pursue EU-GMP

In an effort to add to their international credibility and gain leverage over competitors, more Canadian medical marijuana firms are aiming to achieve one of the highest levels of quality certification in the world. Only a handful of licensed cultivators in Canada qualify for the EU-Good Manufacturing Practices (EU-GMP) certification, giving them an advantage when […]

Read More

Slideshow: 2018 US Cannabis Business Year in Review

2018 marked the historic legalization of recreational marijuana in Canada, the end of hemp prohibition in the United States and huge wins on Election Day for state-legal cannabis and medical marijuana initiatives across the U.S.

Read More

Marlboro maker, Cronos join forces in exclusive CA$2.4 billion deal to tap global cannabis opportunities

Altria Group, one of the largest tobacco companies in North America, has agreed to invest 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group – the most significant foray by Big Tobacco into the rapidly growing cannabis industry to date.

Altria also agreed to make Cronos its exclusive partner for international cannabis opportunities.

Read More

Lawsuit throws German cannabis program into limbo; deadline delayed to Dec. 11

Another lawsuit challenging the application process to grow medical cannabis in Germany could throw the already-delayed domestic cultivation plans even further into a state of uncertainty.

In an update to the public tender, the German Federal Institute for Drugs and Medical Devices (BfArM) disclosed a lawsuit filed in the Dusseldorf Higher Regional Court (OLG Dusseldorf).

Read More

Aphria seeks EU GMP certification before closing deal for German distributor

Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]

Read More

Canadian cannabis firm Aphria approved for NYSE listing

Aphria, one of Canada’s largest cannabis producers, has been approved to list its shares on the New York Stock Exchange. The firm will trade on the NYSE under the ticker symbol APHA starting Nov. 2. The Ontario-based company joins a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More